Page:Niosh tb guidelines.pdf/48

From Wikisource
Jump to navigation Jump to search
This page has been proofread, but needs to be validated.
V.   NIOSH Recommendations for Personal Respiratory Protection
38

Although the data are limited, findings suggest that tuberculosis patients with acquired immunodeficiency syndrome (AIDS), if smear positive, have infectiousness similar to that of tuberculosis patients without AIDS (CDC/New York City Department of Health, unpublished data).

Infectiousness is greatest among patients who have a productive cough, pulmonary cavitation on chest radiograph, and AFB on sputum smear (31). Infection is more likely to result from exposure to a person who has unsuspected pulmonary tuberculosis and who is not receiving antituberculosis therapy or from a person with diagnosed tuberculosis who is not receiving adequate therapy, because of patient noncompliance or the presence of drug-resistant organisms. Administering effective antituberculosis medication has been shown to be strongly associated with a decrease in infectiousness among persons with tuberculosis (25). Effective chemotherapy reduces coughing, the amount of sputum, and the number of organisms in the sputum. However, the length of time a patient must be on effective medication before becoming noninfectious varies (101); some patients are never infectious; whereas those with unrecognized or inadequately treated drug-resistant disease may remain infectious for weeks or months. Thus, decisions about terminating isolation precautions should be made on a case-by-case basis.

In general, persons suspected of having active tuberculosis and persons with confirmed tuberculosis should be considered infectious if cough is present, if cough-inducing procedures are performed, or if sputum smears are known to contain AFB, and if these patients are not on chemotherapy, have just started chemotherapy, or have a poor clinical or bacteriologic response to chemotherapy. A person with tuberculosis who has been on adequate chemotherapy for at least 2-3 weeks and has had a definite clinical and bacteriological response to therapy (reduction in cough, resolution of fever, and progressively decreasing quantity of bacilli on smear) is probably no longer infectious. Most tuberculosis experts agree that noninfectiousness in pulmonary tuberculosis can be established by finding sputum free of bacilli by smear examination on three consecutive days for a patient on effective chemotherapy. Even after isolation precautions have been discontinued, caution should be exercised when a patient with tuberculosis is placed in a room with another patient, especially if the other patient is immunocompromised.

Other guidance has been given by CDC regarding diagnosing tuberculosis and determining the infectiousness of a person with active tuberculosis, for tuberculosis occurring in correctional institutions (33), high-risk populations (76), and long-term-care facilities (34).

C. Selection of Minimal Acceptable Personal Respiratory Protection—Table 3 starting on page 40 summarizes the types of minimal acceptable personal respiratory protection for health-